Initial second-line drug resistance of Mycobacterium tuberculosis isolates from Sudanese retreatment-patients
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 9, 21-23
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north IndiaIndian Journal of Medical Research, 2016
- Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohortBMC Pharmacology and Toxicology, 2015
- Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyThe Lancet, 2012
- Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, ChinaJournal of Clinical Microbiology, 2012
- Retrospective audit of patients treated for MDR-TB in re-treatment category.2009
- Epidemiology and clinical management of XDR-TB: a systematic review by TBNETEuropean Respiratory Journal, 2009
- Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates in ChinaJournal of Clinical Microbiology, 2008
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Extensively drug resistant tuberculosis: Beware patients lost to follow-upBMJ, 2006
- Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005